MYST3 抗体
Recommended next Filters:
您想试用我们的人工智能搜索吗?
16 results
Latest Publications for our MYST3 抗体
: "Identification of MYST3 as a novel epigenetic activator of ERα frequently amplified in breast cancer." in: Oncogene, Vol. 36, Issue 20, pp. 2910-2918, (2016) (PubMed).: "The double PHD finger domain of MOZ/MYST3 induces α-helical structure of the histone H3 tail to facilitate acetylation and methylation sampling and modification." in: Nucleic acids research, Vol. 42, Issue 2, pp. 822-35, (2014) (PubMed).
: "Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells." in: Oncogene, Vol. 29, Issue 36, pp. 5019-31, (2010) (PubMed).
: "Monocytic leukemia zinc finger (MOZ) interacts with p53 to induce p21 expression and cell-cycle arrest." in: The Journal of biological chemistry, Vol. 284, Issue 1, pp. 237-44, (2008) (PubMed).
Aliases for MYST3 抗体
K(lysine) acetyltransferase 6A (kat6a) 抗体lysine acetyltransferase 6A (KAT6A) 抗体
K(lysine) acetyltransferase 6A (Kat6a) 抗体
lysine acetyltransferase 6A (Kat6a) 抗体
1500036M03 抗体
9930021N24Rik 抗体
bmd 抗体
DKFZp469B0815 抗体
moz 抗体
MOZ 抗体
Moz 抗体
myst3 抗体
MYST3 抗体
Myst3 抗体
RUNXBP2 抗体
Runxbp2 抗体
ZC2HC6A 抗体
Zfp220 抗体
ZNF220 抗体
Znf220 抗体
您还需要查找其他产品吗?
- MYST2 抗体
- MYST1 抗体
- MYSM1 抗体
- Myristoylated Alanine-Rich Protein Kinase C Substrate 抗体
- MYRIP 抗体
- Myozenin 3 抗体
- Myozenin 1 抗体
- MYOZ2 抗体
- Myotubularin Related Protein 7 抗体
- Myotubularin Related Protein 6 抗体
- Myotubularin Related Protein 1 抗体
- Myotilin 抗体
- Myosin, Light Chain 12B, Regulatory 抗体
- Myosin XVIIIA 抗体
- Myosin XV 抗体
- Myosin XIX 抗体
- Myosin X 抗体
- Myosin VIIB 抗体
- Myosin VIIA 抗体
- Myosin VI 抗体
- MYT1 抗体
- MYT1L 抗体
- MZB1 抗体
- MZT1 抗体
- N-Acetylneuraminate Pyruvate Lyase (Dihydrodipicolinate Synthase) 抗体
- N-Acylsphingosine Amidohydrolase (Acid Ceramidase) 1 抗体
- N-Cadherin 抗体
- N-Glycanase 1 抗体
- N-Methylpurine-DNA Glycosylase 抗体
- N4BP1 抗体
- N4BP2 抗体
- N4BP2L1 抗体
- N4BP2L2 抗体
- N6AMT1 抗体
- N6AMT2 抗体
- NAA10 抗体
- NAA11 抗体
- NAA15 抗体
- NAA25 抗体
- NAA30 抗体
 
                                     
                                     
                                    